LeapZipBlog: Steve Blade

Steve Blade's blog

1072 blogs

Cytomegalovirus Assay Market to Showcase Vigorous Demand during the Period until 2027

April 18, 2019 by Steve Blade  

Cytomegalovirus Assay Market is fueled owing to rise in prevalence of cytomegalovirus infection, growing awareness among population regarding herpes disease and technological advancement in the diagnosis of the cytomegalovirus. Moreover rise in the initiative taken by the government and development of healthcare infrastructure are anticipated to boost the Cytomegalovirus Assay Market globally. Lack of awareness in developing and under developed countries and price sensitivity are the factor which hinder the growth of the cytomegalovirus assay market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=571

CMV diagnostics turn out to be exceptionally basic for immunocompromised people and pregnant ladies as well. Cytomegaloviruses are one of the main sources of mental hindrance in kids and viral diseases. A cytomegalovirus can cause asymptomatic contaminations in immunocompromised people and can be transmitted to the embryo while pregnancy from his mom, which may show essential or intermittent disease. Hence, it require a proper analysis of essential contamination in the pregnant lady that can be founded on IgG and IgM eagerness assays, a standout amongst the most sensitive serological assays or other ordinary sub-atomic and virological techniques for infection discovery in blood.

Cytomegalovirus has a place with the herpes viridae family and is a twice as stranded as DNA virus. This infection chiefly causes asymptomatic diseases or some of the time causes mild influenza like indications; and later stays dormant all through life, which may relapse. Hence, this infection can stay as a long lasting partner for a few people and can be a quiet killer for the others. Cytomegalovirus (CMV) contamination is described by the improvement of such antibodies, which is caused because of the disease of the infection that stays in a person's body for the duration of his life.

Cytomegalovirus is a common virus which belong to same family as herpesvirus. Cytomegalovirus causes cold sores and chickenpox. Cytomegalovirus is spread through contact spread with someone who have cytomegalovirus. It can also passed through body fluids such as saliva, urine and blood. Cytomegalovirus can cause serious disease such as retinitis, colitis, pneumonia, hepatitis and encephalitis. People with weak immune system can cause severe symptoms which affect eyes, lungs liver. Newborn babies with cytomegalovirus can have brain, liver and growth problems. Hearing loss is caused with the babies having cytomegalovirus infection. Cytomegalovirus is be detected through culture (human fibroblast), PCR, antigen assays, serologies, and cytopathology. Many cytomegalovirus assay are used for the detection of CMV IgG antibodies such as enzyme-linked immunosorbent assay (ELISA), indirect hemagglutination, radioimmunoassay and anticomplement immunofluorescence. Among all enzyme-linked immunosorbent assays (ELISAs) is widely used and is based on crude viral preparations. Congenital CMV infection is been recognized as a leading cause of congenital infection and brain disease in children in U.S. About 20,000 to 40,000 infants are born each year in the U.S. with congenital CMV infection. Development and standardizing molecular diagnostic methods which will result in the availability of reliable, rapid, and simple methods for routine clinical use in near future. In addition, there is also growing interest in examining the feasibility of a cytomegalovirus screening program in conjunction with universal newborn hearing screening in newborn.  Rapid culture methods are more comparable sensitivity and specificity to the standard cell culture assays and the results are available within 24 to 36 hours of sample taken. Saliva PCR assays are currently being assessed as a useful screening method for CMV infection in newborns. CMV infection has led to the development of diagnostic procedures for the rapid identification of CMV disease and infants with congenital infection.

Browse Full Report with TOC- https://www.factmr.com/report/571/cytomegalovirus-assay-market

Increase in cytomegalovirus infection cases propel the growth of the assay market. Patients who have undergone transplantation, new born and premature infants have higher risk of cytomegalovirus infection. New and traditional technique will increase the market of the cytomegalovirus assay market globally. Among all the test type antigenemia assay contributed the largest share which depend on the use of monoclonal antibodies that detect the viral pp65 antigen. The immense pace of research and development activities due to the large presence of biotechnology companies and pharmaceutical are the key factors contributes to the increase in the global cytomegalovirus assay market. Favorable government policies aims at the development of industries such as pharmaceuticals and biotechnology boost the cytomegalovirus assay market globally.

Geographically, Cytomegalovirus Assay Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is projected to hold largest shares in the global market primarily due to growing incidence of Cytomegalovirus and innovations in diagnostic techniques. Asia pacific Cytomegalovirus assay market is anticipated to witness prominent growth during the forecast period owing to increased healthcare expenditure and repeated outbreaks of infectious diseases in developing countries such as India and China.

Cytomegalovirus Assay Market: Key Players

Some of the key players in the Cytomegalovirus Assay Market are Merck KGaA, Qiagen, Abcam plc., Bio Vision Inc., DiaSorin Molecular LLC, Norgen Biotek Corp. among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=571

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

Cold Cast Elastomers Market: Palpable Utility of Cold Cast Elastomers in Industrial Applications

April 18, 2019 by Steve Blade  

According to a recently published Fact.MR report, global sales of cold cast elastomers exceeded 64 Mn tons in 2018, and are poised to record growth at nearly 5% through 2019. The report opines that Asia-Pacific excluding Japan (APEJ) will retain its supremacy in the cold cast elastomers market, undergird by pervasive demand from industrial sectors in the region. Sensing potential opportunities in APEJ, there has been an influx of new product launches by leading cold cast elastomers market stakeholders in recent years.

 Request Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=2918

The recent Fact.MR study estimates that cold cast elastomers sales in industrial applications is expected to exceed 21 million tons in 2019.  This can be primarily attributed to inherent property-based benefits of cold cast elastomers, such as convenience and time-effective production application, thereby reducing operational costs as a consequence. Convenience of manufacturing cold cast elastomers at room temperature, and deprival of heat requirement for curation purposes, continue to drive their sales in industrial applications worldwide.

The robust and elaborate research methodology which was employed during the compilation of the cold cast elastomers market report has been explained thoroughly. A comprehensive analysis of the historical, as well as current data, was performed to produce an authentic and accurate forecast of the cold cast elastomers market. The exhaustive research procedure was divided into two steps namely primary and secondary researches.

Browse Full report with TOC:

https://www.factmr.com/report/2918/cold-cast-elastomers-market

Cold Cast Elastomers Market – Market Structure

The Fact.MR report on cold cast elastomers market provides comprehensive information about the market in terms of the value, volume, Y-o-Y growth, and CAGR. In addition to the valuable information, the cold cast elastomers market provides authentic insights by dividing the cold cast elastomers market on the basis of processing type, geographic region, and end-use applications.

Polyurethane is one of the few chemicals that can be sustainably manufactured. With environmental concerns on the rise and application of stringent regulations for environment conservation, chemical manufacturing is expected to witness a gradual decline. However, potential of manufacturing polyurethane using polyols, and other natural resources are expected to offset challenges associated with declining production of their chemical-based counterparts. Additionally, adoption of plant and other bio-based raw material for the manufacturing of polyurethane will make the process more economical and sustainable.

Polyurethane manufacturing accounts for relatively lower environmental footprint. Due to the growing demand for polyurethane, and constant innovation in sustainable manufacturing processes, the polyurethane industry is estimated to see steady growth which will consequently boost the production of cold cast elastomers.

The cold cast elastomers market remains consolidated, with leading players holding over 40% share of the market. On the other hand, regional and emerging players hold 20-25% and 10-15% share of the cold cast elastomers market respectively. Leading players continue to expand their production facilities, streamline their manufacturing processes, and launch new high-performance elastomer product lines to capitalize on the growing demand for high-functioning elastomers. 

Have Any Query?? Ask Our Industry Expert:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=2918

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

Read Full PR Here:

https://www.factmr.com/media-release/872/cold-cast-elastomers-market

Global Wheat Protein Concentrates Market Driven by Technological Innovations, reports Fact.MR

April 18, 2019 by Steve Blade  

Manufacturers in the wheat protein concentrates market are offering products that are aimed at overcoming high-protein challenges. Strategic launches of this kind are helping the aspiring players of the Wheat Protein Concentrates Market to gain a strategic edge over their rivalry. For instance, Archer Daniels Midland (ADM), a global leader in food processing, introduced a new product ‘Nutriance’ to its existing portfolio to overcome the issue of incorporation of high protein and glutamine levels.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=653

Wheat protein concentrates market is likely to gain tailwinds from the rising popularity for innovative protein concentrates in the food and beverages industry. Surging propensity for high glutamine intake is predicted to be a primary growth lever of wheat protein concentrates market. Moreover, health attributes of wheat protein concentrates, such as enhanced digestibility, is further likely to propel revenue growth of wheat protein concentrates market.

The penetration of nutraceuticals with hydrolysed wheat protein concentrates has been identified as an overarching trend pervading in the wheat protein concentrates market, on the back of their advantages for muscle maintenance. As per the revelation by a cohort of researchers at the University of Maastricht, older men involving regular intake of wheat protein concentrates in large doses saw remarkable gains in muscle size. Such facts provide credence to optimistic future growth aspects of wheat protein concentrates market in the forthcoming years.

Plant-based proteins are high-quality proteins that is primarily obtained from beans & pulses, grains including wheat. These proteins form a very necessary component in the growth and maintenance of the human body and provide additional benefits over animal-derived proteins such as lower body weight, lower cholesterol, and lower blood pressure levels. Wheat proteins are plant-based proteins which has applications in food and beverages, sports nutrition products and meat alternative applications and are used commercially. Adult age groups are the main target segment which consumes wheat protein both in isolate and concentrates forms. However due to the added benefits of plant proteins nowadays the wheat protein market has covered all age group protein consumers. Wheat protein is used as a dietary supplement, rich in proteins and comparably low in carbohydrates.

Wheat proteins are extracted from wheat, this process includes removal of sodium dodecyl sulfate, separation of sodium dodecyl sulfate from insoluble protein fractions in the wheat. Wheat proteins are further divided into isolates, concentrates, and others. 

Key factors which are driving the demand for wheat proteins and wheat protein concentrates are the growing consumer base for vegan diets.  Currently, in the wheat protein market, Wheat protein concentrates are popular as a sports nutrition supplement mostly among body builders and training athletes. Wheat protein concentrates are also an added additive to non-wheat based flours like Almond flour as it maintains the gluten content of flours. 

Browse Full Report with TOC: https://www.factmr.com/report/653/wheat-protein-concentrates-market

 Moreover, there is a high demand of wheat protein in the cosmetics industry currently as there is the presence of gluten in it. Gluten acts as an emulsifier and is a major reason which is leading to the growth of the wheat protein concentrates at present. The wheat protein concentrates are fused in items such as lipsticks, fillers and powders. This is a major reason of growth of wheat protein concentrates market over the forecast period.

Global Wheat Protein Concentrates Market: Key Players

Some of the key players operating in the global Wheat Protein Concentrates market include:

Archer Daniels Midland (ADM), Manildra Group,Gluten Y Almidones Industriales, Cargill Inc., Tereos Syrol, Agrana, Agridient, Honeyville, Glico Nutrition, AB Amilina, Crop Energies AG,  Kroener Staerke, La Roquette  , MGP Ingredients, Crespel & Deiters GmbH and Co. KG

Additionally, Glico Nutrition has focused its products on customizing the wheat proteins for specific food uses, for addition in flours which require high dough strength and extensible texture. NP gluten wheat protein concentrates and isolates perform well in terms of extensibility and are good for making noodles and dumplings wrappers.

Archer Daniels Midland Co.: ADM is expands into the new range of products which are innovative including wheat protein concentrates called Nutriance. Nutriance has about 85% protein is high in glutamine content. This newly added product in company’s range of products is ideal for nutrition, taste, and function.

North America is expected to witness promising growth during the forecast period as the region accounts 35% of the total revenue of the protein market. There is an increasing consumption of nutritional supplements and snacks with the growing number of health-conscious consumers.

A modelling-based approach and triangulation methodology will be followed to estimate data covered in this report. A detailed market understanding and assessment of the distribution channel, species, nature, origin and end use of the product segments covered in the study is followed by carrying out a demand-side approach to estimate the sales of target product segments, which is then cross-referenced with a supply-side assessment of value generated over a pre-defined period. The statistics and data are collected at a regional level, consolidated and synthesized at a global level to estimate the overall market sizes.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=653

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

Wax Removal Aids Market Expected to Deliver Dynamic Progression until 2027

April 18, 2019 by Steve Blade  

The demand of wax removal aids market is fueled owing to introduction of new advanced techniques such as micro suction which is advantageous over conventional technique. Use of microscope headset and calibrated suction device remove excess wax without any introduction of materials or liquids also drive the market of Wax Removal Aids Market. Increase in pollution and smoke in the environment and excessive noise which affect the ear and cause hearing loss are the major factor which drive the wax removal aids market globally. However use of cotton buds and other tools used as compared to the wax removal aids hinder the growth of wax removal aids market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=570

Cerumen commonly known as earwax are natural secretions that enable outer ear canals to clean themselves. However, the buildup of earwax if ignored may significantly impair hearing or cause pain in individuals. The prevalence of impacted earwax leading to complications or a hearing impairment is propelling the need for wax removal tools. The rising uptake of hearing aids across the global population is also increasing this prevalence. In addition, a rising elderly population needing hearing aids may need to get their earwax removed prior to the therapy. These factors are bolstering the demand for wax removal aids. Almost unanimously, physicians and ENT specialists discourage the use of cotton swabs as these are largely ineffective and most likely to accentuate the problem further.

Though various wax softeners are suggested as first line of treatment, a variety of cases may call for the use of mechanical methods of removing the earwax by professionals. The rising demand for various mechanical instruments for the removal of wax is a key factor accentuating the market. Contraindication to such methods and complications during and after the procedure are vital concerns that must be addressed before going through such methods. The growing demand for alternative treatments and advanced wax removal devices is catalyzing the expansion of the market.

Ear wax are known as cerumen which is secreted in ear canal which protect the skin of human ear canal, assists in cleaning and lubrication and also provide protection from fungi, bacteria, insects and water. Ear wax usually don’t cause problem but excessive production of earwax lead to the blockage and pain and hearloss. Earwax also affect operation of hearing aids produce feedback noise and also reduce the quality of sound. Approximately 12 million people a year in the U.S. seek medical care for impacted or excessive cerumen [earwax].serious problem occur when excess of wax is being produced within the ear canal and becomes impacted or compressed which lead to ear pain, sound distortion, persistent itching, unpleasant odor, ringing of the ear (tinnitus), discharge (an oozing substance that keeps appearing), persistent cough, hearing loss. Different wax removal techniques are used at home and by the professionals. At home wax dissolving agents are used. Irrigation, Manual removal with special instruments and suction are the removal techniques used by the professionals. Routine wax removal should be done in order to avoid complications and severe problems related to ear. Many home care services are being provided for the removal of ear wax. Ear wax is removed by the doctor with the help of small curved instrument which is known as curet. ear wax can also be removed or flush out using a water pick or a rubber-bulb syringe filled with warm water. Wax-removal medication, such as carbamide peroxide (Debrox Earwax Removal Kit, Murine Ear Wax Removal System) are also used. Hydrogen peroxide is an effective method of softening ear wax blocking the ear canal. Hydrogen peroxide allows ear wax to gradually soften, and removal by an irrigation method.

Browse Full Report with TOC- https://www.factmr.com/report/570/wax-removal-aids-market

Global Wax Removal Aids Market is segmented by product type, wax removal kits have the largest share due to more demand of kits in clinics as well as homecare settings. Increase in prevalence of hearing loss and noise pollution and problems related to ear propel the growth of wax removal aids in near future. ENT clinics share the largest share among all the end users owing to increase in number of clinics and awareness among the people in underdeveloped and developed countries.

Geographically, Wax Removal Aids Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is leading in the wax removal aids market due to the new techniques available which do not cause pain. Increase in ENT clinics and rise in awareness among the people drive the market of wax removal aids market. Asia Pacific is expected to grow in near future owing to increase in healthcare expenditure and continual upgradation in infrastructure and technology.

Some of the key players in the Wax Removal Aids Market are PC Werth, the Hearing Lab Ltd, Medline Industries, Inc.,Service Providers, Hear4U, Clements Hearing Services, Clarity Hearing Solutions Ltd., Audiology Associates. Some of the service provider include Audiology Medical Services, Bryce Hearing Services amaong others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=570

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

Titanium Dioxide Nanomaterials Market Insights Targeting Technological Expansion Steering Growth during Forecast Period, reports Fact.MR Study

April 18, 2019 by Steve Blade  

 

Titanium dioxide nanomaterials are particles of titanium dioxide with diameters less than 100nm. Since their commercial production, titanium dioxide nanomaterials have been showing promising applications as a pigment in sunscreens, ointments, paints, toothpastes, and so on. Continued research and development have also led to many potential applications of titanium dioxide nanomaterials in areas including photovoltaic, photocatalysis, electrochromics, and sensors. Further, new physical and chemical properties are known to emerge as the size of the material becomes smaller which in turn surge the demand for titanium dioxide nanomaterials.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=698

Rising scope of application along with the possibility to help solve many serious environmental pollution is the key factor driving the global Titanium Dioxide Nanomaterials Market. These materials also have many elements absorbent capacity, which is likely enhance the growth prospects of titanium dioxide nanomaterials market. Significant benefits in products like sunscreen and moisturizer along with growing cosmetic industry are expected to favor the titanium dioxide nanomaterials market growth. However, these materials are closely associated with complex diseases and also been found to be toxic to plants and small organisms which will possibly hamper the market growth. Further, increasing government restriction on the usage of these materials may negatively affect the titanium dioxide nanomaterials market.

ACS Materials, Cristal Inc., American Elements and Other Leading Players Targeting Cosmetics Industry to Consolidate their Position

The research report also includes profiles of key market participants involved in the global titanium dioxide nanomaterials market. Major key participants include ACS Materials, Cristal Inc., American Elements, Huntsman (Sachtleben), Evonik Industries, MKnano, US Research Nanomaterials, Tronox, Sigma-Aldrich and Xuancheng Jingrui New Material. Other participants such as Altairnano, DuPont, Kronos Worldwide, Nanoshel and SkySpring Nanomaterials are also profiled in this extensive research report.

With advent of nanotechnology, research on titanium dioxide nanomaterials gained significant push, which indicated that titanium dioxide nanomaterials manufacturing includes a low cost simple production process. Titanium dioxide nanomaterials are used in various industrial sectors. They are largely used in skin care applications and cosmetics, paints, photovoltaics and electrochromics.

To know more about the Titanium Dioxide Nanomaterials Market Visit the link- https://www.factmr.com/report/698/titanium-dioxide-nanomaterials-market

Moreover, the sale of titanium dioxide nanomaterials has significantly increased with the steady growth in the shipbuilding industry. Titanium dioxide nanomaterials are used in antifouling coatings in order to enhance performance and durability of shipping vessels. In addition, titanium dioxide nanomaterials antifouling coatings are also used in floating offshore and fixed oil rigs. In addition, silver doped titanium dioxide nanomaterials are extensively used in marine antifouling especially while exploring underwater sites as they prevent metal hull corrosion. Titanium dioxide nanomaterials as antifouling agents are expected to gain high traction in the coming years owing to their pollutant degrading and self-cleaning properties.

Will Demand from Paint and Coatings Industry Sustain Growth?

The coatings industry witnessed steady growth in 2017 with decorative coatings gaining high steam since recent past. Use of coatings and paints in the automotive industry is also increasing with growing number of passenger and commercial vehicles, especially across emerging nations. In addition, repainting or recoating has gained sufficient traction owing to vehicle rusting issues in this sector. Asia Pacific reflected high potential for growth of coatings market owing to presence of various end use industries in this region. This is expected to positively influence the use of titanium dioxide nanomaterials as they are widely used in pigments that are applied in coatings and paints. Owing to their strong light scattering and high incident light reflection index, they are largely used as white pigments. This has further increased their application scope across various industries such as plastics, textiles and paper, to name a few.

Moreover, titanium dioxide nanomaterials are used as additives that are used to protect surfaces against bacteria and microbial deterioration and chemical corrosion. Consequently, with growing construction and infrastructure activities coupled with the application of titanium dioxide nanomaterials in this sector is expected to boost their sales in the coming years.

Ambiguity Over Link Between Cancer and Titanium Dioxide Nanomaterials Can Impede Growth Prospects

Initially, ECHA’s committee for assessment of risk suspected that titanium dioxide nanomaterials are closely linked with cancer. Prolonged exposure to titanium dioxide nanomaterials can lead to development of carcinogenic cells, which negatively impacted their use in several industries. However, according to TDMA (Titanium Dioxide Manufacturer’s Association), the link between cancer and titanium dioxide nanomaterials was not appropriately established and there was no evidence of cancerous growth in humans due to titanium dioxide exposure. This initiated the use of titanium dioxide nanomaterials in ink production. Ink manufacturers have been evaluating and reviewing probable toxic effect of titanium dioxide, the results of which reflected that inks with titanium dioxide nanomaterials are not hazardous humans. Thus, growing proliferation of titanium dioxide nanomaterials in ink production is expected to provide a significant impetus to the global titanium dioxide nanomaterials market.

The research report on global titanium dioxide nanomaterials market offers valuable insights along with actionable intelligence on every facet of the global market. Several factors influencing the growth of the titanium dioxide nanomaterials market have been covered in this report. Readers can expect in-depth market analysis along with forecast highlights for a period of nine years, from 2018 till 2027. This research can support in accomplishing reader’s research objectives and milestones to help in grabbing strong hold in the changing titanium dioxide nanomaterials market dynamics.

Compilation of authentic and first-hand intelligence, insights offered in the report are based on quantitative and qualitative assessment by leading industry experts, and inputs from opinion leaders & industry participants around the value chain. Growth determinants, macroeconomic indicators, and parent market trends have been scrutinized and delivered, coupled with the market attractiveness for each market segment encompassed. Qualitative impact of growth influencers on the market segments across regions has also been mapped by the report.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=698

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

Tuberculosis Biomarkers Market Analysis Showcases Growth Trends and Opportunity Forecasted Until 2027

April 18, 2019 by Steve Blade  

The development of biomarkers that can measure responsiveness to treatments and those that assess the risk of developing into full-fledged disease are critical clinical endpoints. Hence, the development and launch of biomarkers that can measure well against such clinical endpoints is the need of the hour, belittling the massive investments made by companies so far. Hence, there is a need for more research that looks into reducing the gap between an emerging panoply of biomarker candidates and their efficacy against targeting product profiles. The need for non-DNA biomarkers to achieve this goal could unlock new, exciting avenues in the Tuberculosis Biomarkers Market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=569

Tuberculosis (TB) biomarkers occupy a central role in the disease characterization, infection and risk assessment, rapid diagnosis, and ultimately cure. Despite considerable volumes of research and the proliferation of biomarker candidates over the past decades, the global market is still characterized by large unmet needs. This is evident in the devastating effect of tuberculosis on the mortality and morbidity in worldwide populations. The market is replete with tuberculosis biomarkers that claim to measure the status of infection and further predict outcomes of vaccination or therapy. But, the fact that none of them is efficacious enough to enable a simple, accurate, and rapid diagnostic test for the infectious disease is a pressing concern.

Tuberculosis is a major dilemma in low and middle- income countries, accounting for second leading cause of death from an infectious disease, globally. The diagnosis of tuberculosis is crucial for controlling the disease. Biomarkers are biological markers which measure and asses as an indicator of normal biological states, pathogenic process, pharmacological responses and future disease risk of patients. The tuberculosis biomarkers can help classify patients at a single time point having active tuberculosis, latent M. tuberculosis or no diseases. In addition, these biomarkers have potential to predict future reactivation risk, support monitoring of the diseases and support in development of new drugs for tuberculosis. Scientists are exploring more about the tuberculosis biomarkers for accurate, cost effective and rapid diagnostic assay for better predictive of tuberculosis treatment outcome. In 2015, Spring Meeting of the Biomarkers and Correlates Working Group (BCWG), tuberculosis experts from around the world, discussed and made recommendations for the TB vaccine community regarding the studies needed to better define biomarkers or correlates for risk of TB infection or disease. Furthermore, there has been an increase in investment of tuberculosis research which have help address shortcomings in tuberculosis biomarkers research and development. For instance, in 2012 The Bill & Melinda Gates Foundation announced $7.7 million funding for 10 new grants to identify biomarkers for diagnosing tuberculosis (TB). Thus, increase in investment and rising research and development activities associated with the tuberculosis biomarkers is anticipated to create new opportunities for the market, during the forecast period

Browse Full Report with TOC- https://www.factmr.com/report/569/tuberculosis-biomarkers-market

Tuberculosis biomarkers market primarily driven by a key factors such as the increasing incidence of tuberculosis. According to the WHO, in 2016 approximately 1.7 million people were dead and 10.4 million new cases were reported, worldwide. The introduction of newer tuberculosis biomarkers is expected to play a crucial role in helping scientist in the characterization and selection of suitable treatment strategies. For instance, in 2016 scientist from Oxford University identified new biomarkers for Tuberculosis (TB) which will provide valuable clues to assess whether potential new vaccines could be effective. The antigen detection technology and biomarkers discovery strategies are rapidly evolving, which is expected to fuel the Tuberculosis biomarkers market growth. Increasing awareness among doctors, patients and technicians in the developing countries would help in promoting the growth of market. However, more chances of experimental failure, ethical issues associated with the tuberculosis diagnosis and treatment, huge investment, time consumption, low validation and independent confirmation of biomarkers limits further development of tuberculosis biomarkers market.

There is no evidence based results showing the best way to treat osteonecrosis and it acts as a restraint in the growth of the Tuberculosis biomarkers market

The global tuberculosis biomarkers market is expected to expand due to increasing rising healthcare burden of tuberculosis among different age groups. Tuberculosis biomarkers market has a presence of many regional players which have a huge market share in emerging countries operating at regional or country level. The future of tuberculosis biomarkers market anticipated with double CAGR during forecasting period. Biologic drug industry is investing on R&D and the key players are focusing on increasing their production capacity for tuberculosis biomarkers.

Global tuberculosis biomarkers market segmented into following regions North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and the Middle East and Africa. North America holds significant market share in the global tuberculosis biomarkers mainly due to the well-established players. The emerging regions in Asia Pacific, Middle East and Africa holds promising future for rise in tuberculosis biomarker market, due to increase in awareness towards the tuberculosis and increase in population simultaneously. In developing economies such as India and China, new industry players are trying to establish their market presence by developing the generic version of the biomarker, through contract research organizations. This is expected to support in reduction in the manufacturing cost for the company and other production related cost.

Key players in the tuberculosis biomarkers market are Antrum Biotech, QIAGEN, Thermo Fisher Scientific, QuantuMDx, and bioMérieux, Abbott, Rapid Biosensor Systems Ltd, GlobalBio Diagnostics Corp., Danaher Corporation, Alere Inc and Cisbio Bioassays.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=569

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

Tilapia Market Expected to Deliver Greater Revenue Share Motivated by Vast Product Preference during 2018-2028

April 18, 2019 by Steve Blade  

The U.S. remains one of the largest importers of Chinese tilapia. However, according to FAO, in the first two quarters of 2017, global tilapia trade witnessed a decline of 6%, attributed to weakening consumer demand, increasing participation of other countries in the global tilapia trade and growing preference for other specialty fishes. A special palate for pangasius has been witnessed among seafood consumers worldwide. Led by Vietnam, nearly half of the global supply of pangasius is held by India, Bangladesh, Indonesia, Malaysia, and China.

Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=649

The U.S. and China continue to remain largest consumers of pangasius. Following the increasing domestic demand and lower prices of pangasius, Chinese tilapia farmers are adopting farming of other fish varieties including pangasius. These dynamics continue to deter the future growth of the Chinese tilapia exports in prominent Tilapia Market.

Amidst Stabilizing Demand Trends, Tilapia Lake Virus (TiLV) Continues to Pose Production Challenges

Tilapia Lake Virus (TiLV) is an emerging threat to global tilapia market where established markets show concern towards risks of introduction of infection through imports. In a bid to avoid a considerable production loss due to TiLV infection, aversion for imports from TiLV-prone countries is observed wherein national markets show increased concern for low quality and possible contamination risks. However, imports continue against the backdrop of widening the supply-demand gap, in turn, adding the risks of production loss.

Although, active surveillance work by governments and development partners is underway aquaculture lacks effective vaccines for viral diseases including TiLV. Owing to this, TiLV continues to remain a challenge for tilapia producing countries.

Tier 3 Companies Continue to Account for Over Half the Tilapia Market Share

As one of the most popular farmed fish, a bulk of tilapia consumption, mostly fresh tilapia is met by domestic production. Especially in the Asian seafood industry, supply chain starts from small fish farmers to big city vendors. China, the world’s largest producer of tilapia also exports only about 10% of its total tilapia production. Following this, the tilapia marketplace continues to remain consolidated among Tier 3 players. In the highly unorganized market, small players continue to leverage opportunities in the domestic tilapia market with their strong local presence and limited regulatory constraints.

Tier 1 and Tier 2 Players Add Diversification to Target High Potential Markets

In 2017, over 95% of the global tilapia production was consumed in the domestic market as cheaper, commoditized tilapia. While a hefty demand of commoditized tilapia is addressed by local players, prominent market players and producers are diversifying their product offerings to target high potential markets in the U.S. and EU28. Eco-labeling, low-antibiotic production processes and convenience packaging are few of the differentiated features added in processed seafood in a bid to establish a clear distinction between commoditized and premium tilapia products. 

To know more about the Tilapia Market Visit the link- https://www.factmr.com/report/649/tilapia-market

Addition of diversity in premium tilapia offerings is meant to target expanding of middle-class and health-conscious urban demographic. While the U.S. imports a bulk of Chinese tilapia, an appetite for tilapia remains considerably lower in the EU28 market. Increasing purchase of premium and pre-prepared seafood products in these leading importer destinations is expected to stimulate the sales of premium tilapia products in the U.S. and EU28.

Frozen Tilapia Fillets Remain Highly Sought After with Increasing Demand on Seafood Aisles

The domestic market witnesses dominance of fresh varieties of tilapia whereas exports are majorly inclined towards frozen varieties, as the nature of commodity is perishable. In addition, increasing palate for this fish has made tilapia one of the most popular fishes consumed in restaurants and seafood aisles. Although a lower volume consumption has been observed in the international tilapia market in past years, demand for frozen fillets continues to capture consumer traction owing to increasing pallet for tilapia fillet dishes and lower prices of frozen varieties as compared to fresh tilapia.

The competitive landscape section of the tilapia market report offers a thorough competitive assessment of the market. Fact.MR provides a comprehensive dashboard view of key market players, company share analysis and thorough company profiles in this section of the tilapia market report. Few of the profiled key market players include Baiyang Aquatic Group, Blue Ridge Aquaculture, Inc., Guangdong Gourmet Aquatic Products Co. Ltd., Ananda Aqua Exports Private Limited, Hainan Xiangtai Fishery Co., Ltd., Beihai Evergreen Aquatic Product Science & Technology Co. Ltd., Regal Springs Tilapia, Mazzetta Company, LLC., North Atlantic Fish Co., Inc. and Netuno Internacional S/A.

Key companies in the tilapia market are engaged in expansion and vertical integration to strengthen market presence and expand their global footprints. For instance, Blue Ridge Aquaculture, Inc., in 2017, opened a new mill – Blue Ridge Aquafeeds with the investment of US$ 5 million. Another prominent player Regal Springs was acquired by Golden Springs Group in 2016. Golden Springs continued the expansion of Regal Springs with its know-how in the life science sector.

Definition

Tilapia is a common name for all types of cichlid fish species. Majorly tilapia are freshwater fishes and rarely found in brackish water. The worldwide popularity of tilapia dishes has led to the introduction of a variety of tilapia products including fresh and frozen varieties of whole tilapia and tilapia fillet.

About the Report

The tilapia market study carried out by Fact.MR has been compiled in the report titled, “Tilapia Market Forecast, Trend Analysis and Competition Tracking – Global Review 2018-2028”. The tilapia market report focuses on prominent trends in the production and marketing space of the market that have a significant impact on the supply-demand equation of the tilapia market during the forecast. The tilapia market report covers all the vital facets of the global marketplace and delivers key insights, challenges and growth opportunities in the tilapia market during the forecast period.

Segmentation

To deliver an all-inclusive outlook of the tilapia market, Fact.MR has divided the report into four segments such as species type, form type, catch type and regions. In the species type segment, the tilapia market has sub-segments namely Nile tilapia, Blue tilapia, Mozambique tilapia and Wami tilapia. Different form of tilapia available in the market are fresh whole tilapia, frozen while tilapia, fresh tilapia fillet and frozen tilapia fillet. Based on catch type, tilapia market is subcategorized into wild catch tilapia and aquaculture tilapia.

Ask an Analyst- https://www.factmr.com/connectus/sample?flag=AE&rep_id=649

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

Global Non-GMO Flour Market Prospects Pinpoint Higher Traction from Developed Nations during 2018-2028

April 18, 2019 by Steve Blade  

The non-GMO flour market is likely to remain influenced with growing consumer inclination toward healthy diet worldwide. Various lifestyle diseases have translated in a paradigm shift toward gluten free food products and non-GMO flour is no exception. The non-GMO flour being organic in nature, facilitate removal of bad fat, supporting in maintaining cardio-vascular health of people. In addition non-GMO flour removes obesogens that stack body fat, which results in lower cholesterol levels.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=650

Growing certifications from regulatory authorities are expected to impact the growth of Non-GMO Flour Market. The USDA (U.S. Department of Agriculture) and Non-GMO Project Verified are two vital certifications that non-GMO flour must undergo in order to enter the commercial market. Main focus behind these stringent certifications on non-GMO flour is to gain consumer confidence on non-GMO flour and other organic products, largely to push the organic trend worldwide. However, though these certifications ensure zero dent in consumer confidence, it becomes difficult for non-GMO flour producers to fully meet certification requirements.

Non-GMO flour market has witnessed regulatory petition against labelling of non-GMO flour. Recently, the Information Technology and Innovative Foundation (ITIF) has filed a petition to the FDA regarding non-GMO flour labelling. According to ITIF, FDA should forbid producers from using non-GMO label on the back of misleading claims and misbranding of products including non-GMO flour. FDA’s decision on labelling of non-GMO products including non-GMO flour is still pending with rules on labelling to be finalized in Q4 2018.

Non-GMO flour is obtained from the milling of non-genetically modified grain (Non-GMO) or a combination of various types of grains and non-grain flour, which essentially has lower gluten content than conventional flour. Non-GMO flour contains several health benefits which are not usually derived from traditional flour or GMO flour. This flour exhibits limited gluten content with improved nutrient quantities, thus offering additional benefits to consumers. Increasing demand for bakery products coupled with the rising trend of gluten-free and Non-GMO Flour products consumption is expected to drive the Non-GMO Flour market over the forecast period.

Rising demand for Non-GMO based Flour food such as bakery products and R.T.E. products along with changing consumer preferences have propelled this market globally. Europe holds a relatively high share of bakery products consumption across the globe. Bread accounts for 79% of the total bakery products consumed in Europe and North America. Bread are consumed on a regular basis and are a staple food in Europe and North America as per capita bread consumption in Europe is approximately 63 kg. R.T.E. products such as cakes, pizza, and biscuits produced by NON-GMO flour are gaining popularity among the youth, which is likely to create further growth opportunities for the Non-GMO flour market.  

To know more about the Non-GMO Flour Market Visit the link- https://www.factmr.com/report/650/nongmo-flour-market

Increasing disposable incomes in western countries and subsequent concerns about healthy, Non-GMO flour-based products consumption are driving the market in this region. Owing to above-mentioned reasons, the demand for bakery products is expected to increase in the coming years and this will lead to the rise in demand for Non-GMO flour across different countries across Europe.

Global Non-GMO Flour Market: Key Players

King Arthur Flours, Bob’s Red Mill, Organic Valley, Hain Celestial, Amy’s kitchen, United Natural Foods, YMT organic Farming, Eden Foods, Chiquita Brands, Albert's Organics, Vert Living Natural Market, Shanghai Green Life Agri-Tech Company, Shanghai Food

Non-GMO flour Products: KAMUT Khorasan wheat grains have never been genetically modified and are free from genetically modified organisms. Bob's red mill produces KAMUT Khorasan wheat grans flour which is a Non-GMO flour in a similar way many producers and manufactures such as Montana flour are using KAMUT Khorasan wheat grains to meet the demand of the Non-GMO flour. Rising concerns about gluten-free products have facilitated the growth of the Non-GMO flour market. The gluten content in flour leads to adverse effects on human health, causing indigestion, intestinal damage, and chronic diarrhea. Health consciousness among consumers coupled with increasing awareness about gluten-free products is driving the Non-GMO flour market globally. Consumers especially in North America and Europe are avoiding GMO flour and are opting for Non-GMO flour products which is a current upcoming trend for this market. This rising health responsiveness has consequently augmented the consumption of substitute, gluten-free varieties of Non-GMO flour such as white rice flour, brown rice flour, maize flour, barley flour, corn flour. Non-GMO flour is a fast expanding food category, demonstrating that this market exhibits immense growth potential over the forecast period. Thus, demand for these products is an imperative factor driving the Non-GMO flour market at present and its influence is expected to continue over the forecast period

A modeling-based approach and triangulation methodology will be followed to estimate data covered in this report. A detailed market understanding and assessment of the key product types, origin, applications and end uses of the product segments covered in the study is followed by carrying out a demand-side approach to estimate the sales of target product segments, which is then cross-referenced with a supply-side assessment of value generated over a pre-defined period. The statistics and data are collected at a regional level, consolidated and synthesized at a global level to estimate the overall market sizes.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=650

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

Psychotic Disorder Treatment Market Growth Overview and Predictions on Size, Share and Trend Through 2027

April 18, 2019 by Steve Blade  

Psychoeducation is another area that merits attention among researchers. This is especially crucial for treating the recurrent episodes of hallucinations and delusions characterized in disorders that may persist life-long. Recent studies seek to shed light on cognitive models of psychotherapy in this regard. Clinicians have been harping on multilevel approach to assess the effectiveness of patient-directed psychoeducation. This is expected to open a new paradigm in the evolution of the Psychotic Disorder Treatment Market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=568

Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable deal of research in nonpharmacologic treatment approaches opening a new avenue in the global psychotic disorder treatment market. These approaches have gained significance of late as they help in boosting medication compliance in patients.

A successful psychotherapy appears promising for managing the patients and may help them adapt to real world faster. Thus, recent studies on cognitive therapy as an adjunct to medication for patients with psychotic disorders augur well for the market expansion.

Psychotic disorders are mental disorders in which a person’s personality is affected severely due to brain damage. When a psychotic episode happens, a person becomes uncertain about reality and usually experiences delusions, hallucinations, off-the-wall behavior, incoherency and chaotic speech. Psychotic disorders generally shows two main symptoms that are hallucinations and delusions. Hallucinations are wrong perceptions, such as seeing, hearing or feeling something that is not present. Delusions are wrong beliefs, involving real-life conditions that could not be true, such as having a disease. Depending on the causes, psychotic disorder can come slowly or quickly. Psychosis is not a permanent state rather it can be cured. The exact cause of psychotic disorder is unclear but psychosis is usually results from brain abnormalities. Psychotic disorder can also be associated with dementia, stroke, schizophrenia, brain tumors, bipolar disorders, heavy use and adverse effect to alcohol or drugs. Medication plays an important role in the treatment of psychotic disorder. Highly-effective treatments are available to treat psychotic disorder which includes antipsychotic medication, cognitive behavioral therapy, supportive psychotherapy and case management.

Browse Full Report with TOC- https://www.factmr.com/report/568/psychotic-disorder-treatment-market

The global psychotic disorder treatment market is anticipated to register a significant CAGR over a forecast period. The increasing research and development activities for the new drugs and new combinations of drugs to minimize the adverse effects  of the antipsychotics drugs and increase safety and efficacy of the drug is anticipated to boost the demand for the psychotic disorder drugs and drives the global psychotic disorder treatment market. Increasing the number of prevalence of severe psychotic disorder is likely to fuel the growth of global psychotic disorder treatment market. The rising in the awareness among people is also anticipated to drives the global psychotic disorder treatment market.

However, the possible side effects of the antipsychotics drugs may hamper the demand for the psychotic disorder treatment and restrain the growth of the global psychotic disorder treatment market. Lack of specific drugs and methods is a significant challenge to ensure the treatment is another factor that hinder the demand for the psychotic disorder treatment and restrain the growth of global psychotic disorder treatment market.

On the basis of regional presence, the global psychotic disorder treatment market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa. Currently, North America is contributing the leading shares to the global psychotic disorder treatment market in terms of value due to increase in the number of prevalence of severe psychotic disorder among people and is anticipated to register a significant CAGR over a forecast period. APEJ is also contributing moderate shares to the market and is expected to show a robust growth to the global psychotic disorder treatment market. Europe is also most lucrative market for the psychotic disorder treatment market. MEA is at a nascent stage to the global psychotic disorder treatment market and anticipated to register a decent growth to the market over a forecast period. Overall, the global psychotic disorder treatment market is expected to show significant growth over a forecast period.

Some of the major market players in psychotic disorder treatment market globally includes: Teva Pharmaceutical Industries Ltd, Sanofi S.A., Allergan, Plc, Pfizer Inc, Novartis International AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, Mylan N.V. and others. These companies are highly focused on the development of advanced Psychotic disorder treatment devices further contributing to the growth of psychotic disorder treatment globally.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=568

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

Global Metominostrobin Market Prospects Pinpoint Higher Traction from Developed Nations during 2018 - 2027

April 18, 2019 by Steve Blade  

The global metominostrobin market is predicted to increase growth with rising focus on research and development. The curative and preventative activities of metominostrobin could attract a whole lot of demand in the market. The fungicide’s residual activity could last close to 50 days and could be directly applied to paddy water or to foliage. Oribright is one of the new metominostrobin fungicides used to control rice blast. It is recommended to apply this fungicide 10 days prior to and after the manifestation of initial symptoms of rice blast. In plants, the fungicide is observed to move basipetally and acropetally.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=687

In a recent research, the bio-efficacy of Metominostrobin 20SC, a new generation fungicide, was investigated by the author of the paper affiliated with Rice Research Station, Chinsurah in West Bengal, India. The investigation was mainly about the fungicide’s performance in eliminating Sheath Blight disease of rice. With just two sprays, the fungicide was reported to considerably improve grain yield and also gain effective control of the rice disease. The investigation was performed versus a comparative fungicide. Tricyclazole and hexaconazole were used alongside the new fungicide as check fungicide options currently recommended.

In February 2017, Summit Agro International acquired rights from Bayer CropScience to sell metominostrobin in Japan.

The global metominostrobin market report by FactMR is a complete market research analysis. Study of past, present, and future trends of the industry offers a comprehensive outlook of the growth of the Global Metominostrobin Market during the forecast period between 2018 and 2027.

Amidst the challenge of increased productivity, global agricultural sector is seeking novel and effective pesticides to protect the crop and increase the yield. Population growth, changing tastes, and technology advances in the agricultural sector have significantly contributed to the management of increased productivity pressure. And these factors, in turn, hold significant influence over the growth of the global metominostrobin market.

Developed since 1996, Metominostrobin is classified under the most common fungicide group called strobilurins. Strobilurins are, in turn, classified under QoI or quinone outside inhibitor according to their mode of action. Metominostrobin is a broad-spectrum, systemic, preventive, and curative fungicide applied to control the fungal diseases in rice, wheat, soya bean, cotton, kidney beans, and corn. The first commercial metominostrobin was made available in market by Shionogi in 1999. Primarily designed for rice crop, this fungicide is under study for its utilization in other crops as well.

Browse Full Report with TOC: https://www.factmr.com/report/687/metominostrobin-market

In 2014, Sumitomo Agro International, a subsidiary of Sumitomo Corporation acquired Bayer Crop Science Japan’s metominostrobin. The acquisition allowed Sumitomo to distribute and market the fungicide, however, the sales and development of the metominostrobin were retained by Bayer Crop Science. In 2017, both the organizations have agreed to initiate joint efforts to develop new fungicides to control soya bean disease in Brazil.

As of 2018, key stakeholders in the global metominostrobin market include Summit Agro China, Sumitomo Corporation, Bayer Crop Science, Shionogi, Syngenta, and Jiangsu Furun Biochemical Technology among others.

The agriculture community is expected to feed approximately 9.7 billion global population in 2050. To accommodate this demand, a two-fold rise in the cereal crop production is expected from farmer’s community. Due to this, increased productivity has become an important challenge. With the aim of higher yield production, the community has actively adopted modern farming methods including use of chemicals such as pesticides and fungicides. Following this trend, the market for metominostrobin is likely to witness persistent growth in future.

Recently, Sumitomo’s metominostrobin has received approval from the National Health Surveillance Agency (Anvisa) in Brazil, the second largest soya bean producing country. The approval covers foliar application of the fungicide on six crops including corn, soya bean, rice, wheat, cotton, and kidney beans. Argentina, world’s leading soya bean producer, has already received a registration approval for metominostrobin as a Crop Protection product. Along with Argentina and other Latin American countries including Columbia, Peru, Eucador, and Bolivia are leading soya bean producers across the globe have also received the approval. Asian Fruit and cereal producers such as Vietnam, Philippines, Indonesia, Malaysia and other important rice cultivators including India, Pakistan and Shri Lanka have a significant market presence of metominostrobin.

Over 60% of the world population relies on rice that serves as a staple food for major world communities. Out of total world rice grain production, approximately 90% is produced as well as consumed in Asia, helmed by India. According to Foreign Agricultural services, USDA, in the month if April 2018, higher rice production was reported in Asian countries such as Pakistan, Philippines, Shri Lanka, and other world countries such as Brazil, Columbia, and Burma. Several studies have shown effective fungal disease control in rice with the use of metominostrobin as compared to other fungicides available in the market. As it provides effective disease control and gives higher grain yield, metomionostrobin is highly preferred in paddy fields.

Rice blast caused by Magnaporthe oryzae is the most important rice disease destroying almost every plant part such as leaves, stems, peduncles, seeds, panicles, and also roots. Although chemical control assists in management of such fungal diseases, the rice crop remains vulnerable to the disease, due to pathogen’s ability to rapidly adapt and alter genetic composition for survival. Development of resistant strain or hybrid combinations is effective and economical for disease management. Owing to which, several R&D efforts are underway to develop resistant strains. As these strains are intrinsically resistant to fungal pathogens, if successfully developed, demand for fungicides including metominostrobin may decline in future.

Above discussed market scenarios are thoroughly discussed in the report making it the most credible source for business professionals to understand the outlook of the global metominostrobin market.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=687

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/